PCSK9を標的とした抗体産生を誘導する脂質異常症新規治療ワクチンの開発

• Project/Area Number: 20K17153
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 53020:Cardiology-related
• Research Institution: Kagawa University
• Principal Investigator: 河上 良 香川大学, 医学部附属病院, 助教 (50771961)
• Project Period (FY): 2020-04-01 – 2023-03-31
• Project Status: Declined (Fiscal Year 2020)
• Budget Amount: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000); Fiscal Year 2022: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000); Fiscal Year 2021: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000); Fiscal Year 2020: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)